Pharma’s Pervasive Influence Corrupts Medicine both sides of Atlantic Tue, 4 Oct 2005 The focus of criticism in medicine has shifted from cost and barriers to access to treatments to an examination of the safety and benefit of current treatments. The pharmaceutical industry’s corrupting influence on physicians, academic researchers, the…
Loren Mosher dissident psychiatrist obits Tue, 20 Jul 2004 The untimely death of Dr. Loren Mosher leaves a great vacuum in the mental health reform movement–as few psychiatrists have had the moral courage to stand up with their patients against the abuses wrought by the “unholy alliance” of psychiatry, Big…
Fast growing business: Unethical clinical trials in India – Asia Times Tue, 27 Jul 2004 Asia Times reports: “India increasingly emerges as a preferred destination for outsourcing clinical trials – testing of new drugs on humans – the country may also be heading toward providing the greatest source of human…
July 16, 2002 Genetic Testing Raises Tough Ethical Questions FYI An Op Ed article in The New York Times, by Susan Love, MD, sheds light on the faulty assumptions that led to the discovery that hormone replacement therapy did not deliver on its promises. “There is a tendency, driven by…
July 18, 2002 Anthrax Vaccine Not Safe and Effective – Emergency Medicine News FYI In her letter in the July issue of Emergency Medicine News (below) Dr. Meryl Nass cites a body of evidence linking the anthrax vaccine with systemic adverse medical reactions, and 100,000 to possibly 200,000 veterans who…
Hormone Replacement “Bombshell” is Not and isolated incident Wednesday, July 10, 2002 Until a “bombshell” study overturned hormone replacement treatment (HRT), Premarin was the most prescribed drug in U.S. in the last decade (45 million Rx in 2001) and Prempro the most prescribed estrongen / progesterone combination (22 million Rx…
“The Drug Trial That Went Wrong” is an investigative report by Chanel 4 (UK) about the circumstances surrounding the near fatal drug trial testing the safety of TGN1412, a monoclonal antibody drug, conducted in March 2006 at London’s Northwick Park Hospital. [1] http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/5377226.stm It airs momorrow.
A study published in The Journal of the National Cancer Institute, found that advanced chemotherapy put patients at far greater
risks of harm than adverse effect reports from clinical trial data reveal.
USA Today reports that last year the pharmaceutical industry "faced the most product liability lawsuits of any other industry."
When the Times refers to an experiment as "bold and controversial" the reporter is sanitizing the fact that the experiment is UNETHICAL—it violates medicine’s cardinal rule "First, do no harm."
Three reports illustrate the wide and deepening disconnect between medicine under the influence of pharmaceutical industry marketing goals and scientific evidence that contradicts current practice and public health policies:
A front page report in The New York Times provides additonal information about the catastrophic TGN1412 medical experiment in which 6 previously healthy volunteers were intravenously injected with monoclonal antibody in a highly risky procedure.
